JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB310538

Alexa Fluor® 594 Anti-GLUD1 + GLUD2 抗体 [EPR11370]

Alexa Fluor® 594 Anti-GLUD1 + GLUD2 antibody [EPR11370]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal GLUD1 antibody - conjugated to Alexa Fluor® 594. Suitable for Target Binding Affinity, Antibody Labelling, Flow Cyt (Intra), ICC/IF, IHC-P and reacts with Human samples.

別名を表示する

GLUD, GLUD1, GDH 1, GLUDP1, GLUD2, GDH 2

関連する標識済み抗体及び組成の異なる製品 (10)

  • Unconjugated

    Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • Carrier free

    Anti-GLUD1 + GLUD2 antibody [EPR11370] - BSA and Azide free

  • 660 APC

    APC Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • HRP

    HRP Anti-GLUD1 + GLUD2 antibody [EPR11370]

  • 578 PE

    PE Anti-GLUD1 + GLUD2 antibody [EPR11370]

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR11370

アイソタイプ

IgG

標識

Alexa Fluor® 594

励起波長/蛍光波長

Ex: 590nm, Em: 617nm

キャリアフリー

No

交差種

Human, Mouse, Rat

アプリケーション

Antibody Labelling, ICC/IF, IHC-P, Flow Cyt (Intra), Target Binding Affinity

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

組合せ製品

Assay Kits

AB102527

Glutamate Dehydrogenase Activity Assay Kit

Functional Studies - Glutamate Dehydrogenase Activity Assay Kit (AB102527)

  • 0
  • 0
Primary Antibodies

AB305456

PE Anti-GLUD1 + GLUD2 antibody [EPR11370]

RabMAb|Recombinant|Trial Size|Trial Size

  • 0
  • 0
Primary Antibodies

AB212122

PE Anti-IDH2 antibody [EPR7577]

RabMAb|Recombinant|KO Validated|Trial Size

Flow Cytometry (Intracellular) - PE Anti-IDH2 antibody [EPR7577] (AB212122)

  • 5
  • 1
Primary Antibodies

AB204473

Alexa Fluor® 647 Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292]

RabMAb|Recombinant|Trial Size

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 647 Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (AB204473)

  • 5
  • 1
Primary Antibodies

AB216385

Alexa Fluor® 594 Anti-ATP5A antibody [EPR13030(B)] - Mitochondrial Marker

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 594 Anti-ATP5A antibody [EPR13030(B)] - Mitochondrial Marker (AB216385)

  • 4
  • 1
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "TargetBindingAffinity" : {"fullname" : "Target Binding Affinity", "shortname":"Target Binding Affinity"}, "AntibodyLabelling" : {"fullname" : "Antibody Labelling", "shortname":"Antibody Labelling"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "TargetBindingAffinity-species-checked": "guaranteed", "TargetBindingAffinity-species-dilution-info": "", "TargetBindingAffinity-species-notes": "", "AntibodyLabelling-species-checked": "guaranteed", "AntibodyLabelling-species-dilution-info": "", "AntibodyLabelling-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "TargetBindingAffinity-species-checked": "predicted", "TargetBindingAffinity-species-dilution-info": "", "TargetBindingAffinity-species-notes": "", "AntibodyLabelling-species-checked": "predicted", "AntibodyLabelling-species-dilution-info": "", "AntibodyLabelling-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "TargetBindingAffinity-species-checked": "predicted", "TargetBindingAffinity-species-dilution-info": "", "TargetBindingAffinity-species-notes": "", "AntibodyLabelling-species-checked": "predicted", "AntibodyLabelling-species-dilution-info": "", "AntibodyLabelling-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }
style
left-column

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle|Store in the dark
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

GLUD1 and GLUD2 also known as glutamate dehydrogenases 1 and 2 are enzymes that convert glutamate to α-ketoglutarate linking amino acid metabolism with the tricarboxylic acid cycle. GLUD1 has a mass of approximately 56 kDa while GLUD2 has a similar mass range. GLUD1 expresses ubiquitously in most tissues including the liver and brain whereas GLUD2 predominantly expresses in the brain and testes. These enzymes play a significant role in cellular energy metabolism and neurotransmitter regulation.
Biological function summary

GLUD1 and GLUD2 enzymes act in mitochondrial processes where they catalyze oxidative deamination of glutamate. This reaction facilitates removal of excess nitrogen and supports energy balance within cells. These enzymes do not form part of larger complexes but operate independently within the mitochondrial matrix. The differential expression of GLUD1 and GLUD2 suggests specialized roles in nervous system metabolism with GLUD2 potentially adapting to higher demand for neurotransmitter turnover in the brain.

Pathways

Components including GLUD1 and GLUD2 participate in the glutamate metabolism pathway and the urea cycle intimately linking key points of nitrogen and carbon metabolism. These enzymes influence the tricarboxylic acid cycle by producing α-ketoglutarate a critical molecule. Their activity intersects with proteins such as IDH1 and IDH2 isocitrate dehydrogenases that also alter tricarboxylic acid cycle fluxes coordinating cellular responses to metabolic needs and stress conditions.

GLUD1 and GLUD2 mutations can connect to hyperinsulinism/hyperammonemia syndrome where dysregulated enzyme activity leads to abnormal ammonia and insulin levels. Their role in the nervous system connects them to neurodegenerative disorders like Alzheimer's disease where altered glutamate metabolism may contribute to disease progression. The relationship with proteins like APP (amyloid precursor protein) emphasizes the broader implications of GLUD pathways in neural tissue health and disease.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Mitochondrial glutamate dehydrogenase that catalyzes the conversion of L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle (PubMed : 11032875, PubMed : 11254391, PubMed : 16023112, PubMed : 16959573). Plays a role in insulin homeostasis (PubMed : 11297618, PubMed : 9571255). May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate (By similarity).
See full target information GLUD1

追加のターゲット

GLUD2
style
left-column
style
left-column
style
right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com